---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-005802"
form_type: "8-K"
ticker: "ITGR"
cik: "0001114483"
company_name: "Integer Holdings Corp"
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:20:42.766363+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Integer Q3 sales +9% to $431M; raises FY outlook; promotes Khales to COO

## Summary
- Q3 sales $431M (+9% YoY), organic +4%; GAAP op income $58M (+19%), adj op income $76M (+17%).
- GAAP diluted EPS $1.01; adj EPS $1.43; adj EBITDA $96M (+18%).
- Raises FY 2024 adj op income midpoint to $280-288M (+18-22%); FY sales $1.707-1.727B (+10-11%).
- Electrochem divestiture for $50M cash on track to close October 2024.
- Khales promoted to COO, Senn to President Cardio & Vascular; both effective Q1 2025.

## SEC filing metadata
- accession: 0001171843-24-005802
- form_type: 8-K
- ticker: ITGR
- cik: 0001114483
- company_name: Integer Holdings Corp
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1114483/000117184324005802/0001171843-24-005802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1114483/000117184324005802/f8k_102424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-005802
- JSON: https://secwatch.observer/filing/0001171843-24-005802.json
- Plain text: https://secwatch.observer/filing/0001171843-24-005802.txt

## Key facts
- Executive change
  Andrew Senn was appointed as President, Cardio and Vascular at Integer Holdings Corp.
  - Action: appointed
  - Role: President, Cardio and Vascular
  source text: In connection therewith, Andrew Senn, who currently serves as Senior Vice President, Strategy, Business Development and Investor Relations, has been appointed to serve as President, Cardio and Vascular.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1114483/000117184324005802/0001171843-24-005802-index.htm
- Executive change
  Payman Khales changed role as Chief Operating Officer at Integer Holdings Corp.
  - Action: promoted
  - Role: Chief Operating Officer
  source text: On October 24, 2024, the Company announced that Payman Khales, who currently serves as the Company’s President, Cardio & Vascular, has been promoted to serve in the newly created role of Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1114483/000117184324005802/0001171843-24-005802-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.